Cevimeline
RxNorm 44281
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 44281 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cevimeline.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Cevimeline
(Atom ID: 503949)
PTPrescribable
Designated preferred name (PT):
Cevimeline
(Atom ID: 503955)
FNPrescribable
Full form of descriptor (FN):
Cevimeline (substance)
(Atom ID: 503960)
PTPrescribable
Designated preferred name (PT):
Cevimeline-containing product
(Atom ID: 10799354)
FNPrescribable
Full form of descriptor (FN):
Product containing cevimeline (medicinal product)
(Atom ID: 9254968)
Patient Education
Cevimeline
Cevimeline is used to treat the symptoms of dry mouth in patients with Sjogren's syndrome (a condition that affects the immune system and causes dryness of certain parts of the body such as the eyes and mouth). Cevimeline is in a class of medications called cholinergic agonists. It works by increasing the amount of saliva in the mouth.
[Learn More]
* Please review the disclaimer below.